Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Nature Chemical Biology
|
January 16, 2023
Modeling the expansion of virtual screening libraries
Jiankun Lyu, John J Irwin, Brian K Shoichet
Journal of Medicinal Chemistry
|
June 9, 2016
Discovery and Rational Design of Pteridin-7(8H)-one-Based Inhibitors Targeting FMS-like Tyrosine Kinase 3 (FLT3) and Its Mutants
Deheng Sun, Yu Yang, Jiankun Lyu, et al.
Journal of Medicinal Chemistry
|
July 11, 2018
Selectivity Challenges in Docking Screens for GPCR Targets and Antitargets
Dahlia R Weiss, Joel Karpiak, Xi-Ping Huang, et al.
Oncotarget
|
August 18, 2016
Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor
Qiao Li, Lina Quan, Jiankun Lyu, et al.
Scientific Reports
|
June 21, 2017
Structure-Guided Design of C4-alkyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-ones as Potent and Mutant-Selective Epidermal Growth Factor Receptor (EGFR) L858R/T790M Inhibitors
Yongjia Hao, Jiankun Lyu, Rong Qu, et al.
Journal of Chemical Information and Modeling
|
January 26, 2021
Property-Unmatched Decoys in Docking Benchmarks
Reed M Stein, Ying Yang, Trent E Balius, et al.
Bioorganic & Medicinal Chemistry
|
July 28, 2015
Antiproliferative and apoptosis-inducing activities of novel naphthalimide-cyclam conjugates through dual topoisomerase (topo) I/II inhibition
Shaoying Tan, Deheng Sun, Jiankun Lyu, et al.
Journal of Medicinal Chemistry
|
June 16, 2018
Design, Synthesis, and Biological Evaluation of Pyrimido[4,5- d]pyrimidine-2,4(1 H,3 H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation
Yongjia Hao, Jiankun Lyu, Rong Qu, et al.
Nature Protocols
|
December 10, 2021
Publisher Correction: A practical guide to large-scale docking
Brian J Bender, Stefan Gahbauer, Andreas Luttens, et al.
Nature Protocols
|
September 25, 2021
A practical guide to large-scale docking
Brian J Bender, Stefan Gahbauer, Andreas Luttens, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Nature Chemical Biology
|
January 16, 2023
Modeling the expansion of virtual screening libraries
Jiankun Lyu, John J Irwin, Brian K Shoichet
Journal of Medicinal Chemistry
|
June 9, 2016
Discovery and Rational Design of Pteridin-7(8H)-one-Based Inhibitors Targeting FMS-like Tyrosine Kinase 3 (FLT3) and Its Mutants
Deheng Sun, Yu Yang, Jiankun Lyu, et al.
Journal of Medicinal Chemistry
|
July 11, 2018
Selectivity Challenges in Docking Screens for GPCR Targets and Antitargets
Dahlia R Weiss, Joel Karpiak, Xi-Ping Huang, et al.
Oncotarget
|
August 18, 2016
Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor
Qiao Li, Lina Quan, Jiankun Lyu, et al.
Scientific Reports
|
June 21, 2017
Structure-Guided Design of C4-alkyl-1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-ones as Potent and Mutant-Selective Epidermal Growth Factor Receptor (EGFR) L858R/T790M Inhibitors
Yongjia Hao, Jiankun Lyu, Rong Qu, et al.
Journal of Chemical Information and Modeling
|
January 26, 2021
Property-Unmatched Decoys in Docking Benchmarks
Reed M Stein, Ying Yang, Trent E Balius, et al.
Bioorganic & Medicinal Chemistry
|
July 28, 2015
Antiproliferative and apoptosis-inducing activities of novel naphthalimide-cyclam conjugates through dual topoisomerase (topo) I/II inhibition
Shaoying Tan, Deheng Sun, Jiankun Lyu, et al.
Journal of Medicinal Chemistry
|
June 16, 2018
Design, Synthesis, and Biological Evaluation of Pyrimido[4,5- d]pyrimidine-2,4(1 H,3 H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation
Yongjia Hao, Jiankun Lyu, Rong Qu, et al.
Nature Protocols
|
December 10, 2021
Publisher Correction: A practical guide to large-scale docking
Brian J Bender, Stefan Gahbauer, Andreas Luttens, et al.
Nature Protocols
|
September 25, 2021
A practical guide to large-scale docking
Brian J Bender, Stefan Gahbauer, Andreas Luttens, et al.
Page
of 3